Carlo Cifani Selected Research

Carlo Cifani Research Topics

Disease

17	Bulimia (Binge Eating) 10/2021 - 05/2009
13	Obesity 03/2022 - 01/2015
10	Feeding and Eating Disorders (Eating Disorder) 10/2021 - 12/2010
9	Body Weight (Weight, Body) 10/2021 - 03/2016
4	Alcoholism (Alcohol Abuse) 11/2021 - 11/2006
3	Inflammation (Inflammations) 01/2022 - 03/2020
3	Substance-Related Disorders (Drug Abuse) 07/2020 - 02/2012
2	Hypertrophy 04/2022 - 03/2020
2	Neoplasms (Cancer) 01/2022 - 03/2015
2	Pain (Aches) 11/2021 - 01/2020
2	Hyperphagia (Overeating) 10/2020 - 05/2011
2	Overweight 11/2018 - 01/2015
2	Shock 01/2018 - 01/2006
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2011 - 04/2009
1	Wounds and Injuries (Trauma) 03/2022
1	Cytokine Release Syndrome 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Endometriosis 01/2022
1	Sepsis (Septicemia) 01/2022
1	Atherosclerosis 01/2022
1	Fever (Fevers) 12/2021
1	Encephalitis (Encephalitis, Rasmussen) 12/2021
1	Stroke (Strokes) 12/2021
1	Ischemic Stroke 12/2021
1	Nervous System Diseases (Neurological Disorders) 11/2021
1	Hyperlipidemias (Hyperlipidemia) 03/2021
1	Mood Disorders (Mood Disorder) 02/2021
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2021

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2019
4	Messenger RNA (mRNA)IBA 08/2021 - 03/2015
4	EndocannabinoidsIBA 01/2021 - 03/2015
3	Biological ProductsIBA 11/2021 - 01/2020
3	Neurotransmitter Agents (Neurotransmitter)IBA 03/2021 - 08/2014
3	Insulin (Novolin)FDA Link 05/2020 - 11/2018
3	Purinergic P1 Receptors (Adenosine Receptor)IBA 12/2019 - 02/2012
3	Cocaine (Cocaine HCl)IBA 01/2018 - 04/2009
3	NociceptinIBA 07/2013 - 04/2009
2	CytokinesIBA 01/2022 - 01/2017
2	EnzymesIBA 01/2022 - 10/2021
2	Pharmaceutical PreparationsIBA 11/2021 - 08/2014
2	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 11/2018
2	AntioxidantsIBA 05/2021 - 03/2020
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2021 - 01/2019
2	NeuropeptidesIBA 04/2020 - 01/2015
2	CorticosteroneIBA 04/2020 - 10/2017
2	Peptides (Polypeptides)IBA 04/2020 - 01/2015
2	Opioid Analgesics (Opioids)IBA 01/2020 - 01/2019
2	CholesterolIBA 01/2020 - 11/2017
2	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2020 - 01/2019
2	CRF receptor type 1IBA 10/2017 - 08/2014
2	R 121919IBA 10/2017 - 08/2014
2	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 10/2017 - 08/2014
2	Ethanol (Ethyl Alcohol)IBA 01/2017 - 02/2012
2	Amphetamine (Amfetamine)FDA LinkGeneric 05/2011 - 04/2009
1	Proteins (Proteins, Gene)FDA Link 04/2022
1	Cholinergic Agents (Cholinergics)IBA 03/2022
1	PF-562271IBA 01/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022
1	E-SelectinIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2022
1	Focal Adhesion Kinase 2IBA 01/2022
1	InflammasomesIBA 01/2022
1	NF-kappa B (NF-kB)IBA 12/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2021
1	Interleukin-6 (Interleukin 6)IBA 12/2021
1	Dinoprostone (PGE2)FDA Link 12/2021
1	Dihydrotachysterol (AT 10)IBA 12/2021
1	Ion Channels (Ion Channel)IBA 11/2021
1	Hormones (Hormone)IBA 10/2021
1	AcyltransferasesIBA 10/2021
1	Peptide Hormones (Polypeptide Hormones)IBA 10/2021
1	GhrelinIBA 10/2021
1	Oxidants (Oxidizing Agents)IBA 05/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2021
1	PhytochemicalsIBA 03/2021
1	FlavonoidsIBA 03/2021
1	CannabidiolIBA 02/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Acetates (Acetic Acid Esters)FDA Link 01/2021
1	Pyruvic Acid (Pyruvate)IBA 01/2021
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2021
1	Threonine (L-Threonine)FDA Link 01/2021
1	MelanocortinsIBA 11/2020
1	IncretinsIBA 08/2020
1	Blood Proteins (Serum Proteins)IBA 08/2020
1	Dietary Advanced Glycation End ProductsIBA 08/2020
1	Dopamine D4 Receptors (Dopamine D4 Receptor)IBA 07/2020
1	MicroRNAs (MicroRNA)IBA 04/2020
1	Superoxide DismutaseIBA 03/2020

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 10/2020 - 01/2019
2	Injections 10/2017 - 08/2014
1	Ligation 01/2022
1	Punctures 01/2022
1	Oral Administration 10/2021